NSCLC PATIENTS WITH BOTH WILDTYPE EGFR AND HIGH CD151 EXPRESSION HAVE POORER DISEASE OUTCOME
23rd Congress of the Asian Pacific Society of Respirology, 29 Nov - 2 Dec 2018
Saved in:
Main Authors: | Wong, Amanda, Nga, Min En, Wong, Hung Chew, Soo, Ross, An, Omer, Yang, Henry, Tam, John KC, Seet, Ju Ee, Lim, Yaw Chyn, Thai, Tran |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Conference or Workshop Item |
Published: |
WILEY
2019
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/155284 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
CLINICAL AND FUNCTIONAL SIGNIFICANCE OF CD151 IN WILDTYPE EGRF NSCLC
by: WONG HUEE PING AMANDA
Published: (2020) -
Clinical Benefit of EGFR-TKI in Management of NSCLC
by: Siprianus Ugroseno Yudho Bintoro
Published: (2017) -
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
by: Suresh S. Ramalingam, et al.
Published: (2020) -
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
by: Suresh S. Ramalingam, et al.
Published: (2020) -
Relationship Between Expression of MAGE-A3 with The Histopathology in NSCLC Patients
by: Mokhammad Mukhlis, -, et al.
Published: (2021)